BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 15739554)

  • 1. Neuroradiographic changes following convection-enhanced delivery of the recombinant cytotoxin interleukin 13-PE38QQR for recurrent malignant glioma.
    Parney IF; Kunwar S; McDermott M; Berger M; Prados M; Cha S; Croteau D; Puri RK; Chang SM
    J Neurosurg; 2005 Feb; 102(2):267-75. PubMed ID: 15739554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety of intraparenchymal convection-enhanced delivery of cintredekin besudotox in early-phase studies.
    Kunwar S; Chang SM; Prados MD; Berger MS; Sampson JH; Croteau D; Sherman JW; Grahn AY; Shu VS; Dul JL; Husain SR; Joshi BH; Pedain C; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E15. PubMed ID: 16709020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convection enhanced delivery of IL13-PE38QQR for treatment of recurrent malignant glioma: presentation of interim findings from ongoing phase 1 studies.
    Kunwar S
    Acta Neurochir Suppl; 2003; 88():105-11. PubMed ID: 14531568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase I trial of convection-enhanced delivery of IL13-Pseudomonas toxin in children with diffuse intrinsic pontine glioma.
    Heiss JD; Jamshidi A; Shah S; Martin S; Wolters PL; Argersinger DP; Warren KE; Lonser RR
    J Neurosurg Pediatr; 2018 Dec; 23(3):333-342. PubMed ID: 30544335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct intracerebral delivery of cintredekin besudotox (IL13-PE38QQR) in recurrent malignant glioma: a report by the Cintredekin Besudotox Intraparenchymal Study Group.
    Kunwar S; Prados MD; Chang SM; Berger MS; Lang FF; Piepmeier JM; Sampson JH; Ram Z; Gutin PH; Gibbons RD; Aldape KD; Croteau DJ; Sherman JW; Puri RK;
    J Clin Oncol; 2007 Mar; 25(7):837-44. PubMed ID: 17327604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cintredekin besudotox in treatment of malignant glioma.
    Mut M; Sherman JH; Shaffrey ME; Schiff D
    Expert Opin Biol Ther; 2008 Jun; 8(6):805-12. PubMed ID: 18476792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of hyperintense signal on T2-weighted MR images correlates with infusion distribution from intracerebral convection-enhanced delivery of a tumor-targeted cytotoxin.
    Sampson JH; Raghavan R; Provenzale JM; Croteau D; Reardon DA; Coleman RE; Rodríguez Ponce I; Pastan I; Puri RK; Pedain C
    AJR Am J Roentgenol; 2007 Mar; 188(3):703-9. PubMed ID: 17312057
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-13 receptor-directed cytotoxin for malignant glioma therapy: from bench to bedside.
    Husain SR; Puri RK
    J Neurooncol; 2003 Oct; 65(1):37-48. PubMed ID: 14649884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The IL-4 and IL-13 pseudomonas exotoxins: new hope for brain tumor therapy.
    Shimamura T; Husain SR; Puri RK
    Neurosurg Focus; 2006 Apr; 20(4):E11. PubMed ID: 16709016
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Convection-enhanced delivery of cintredekin besudotox (interleukin-13-PE38QQR) followed by radiation therapy with and without temozolomide in newly diagnosed malignant gliomas: phase 1 study of final safety results.
    Vogelbaum MA; Sampson JH; Kunwar S; Chang SM; Shaffrey M; Asher AL; Lang FF; Croteau D; Parker K; Grahn AY; Sherman JW; Husain SR; Puri RK
    Neurosurgery; 2007 Nov; 61(5):1031-7; discussion 1037-8. PubMed ID: 18091279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local convection enhanced delivery of IL4-Pseudomonas exotoxin (NBI-3001) for treatment of patients with recurrent malignant glioma.
    Weber FW; Floeth F; Asher A; Bucholz R; Berger M; Prados M; Chang S; Bruce J; Hall W; Rainov NG; Westphal M; Warnick RE; Rand RW; Rommell F; Pan H; Hingorani VN; Puri RK
    Acta Neurochir Suppl; 2003; 88():93-103. PubMed ID: 14531567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Convection-enhanced delivery of interleukin-13 receptor-directed cytotoxin for malignant glioma therapy.
    Kioi M; Husain SR; Croteau D; Kunwar S; Puri RK
    Technol Cancer Res Treat; 2006 Jun; 5(3):239-50. PubMed ID: 16700620
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interstitial infusion of IL13-PE38QQR in the rat brain stem.
    Souweidane MM; Occhiogrosso G; Mark EB; Edgar MA
    J Neurooncol; 2004 May; 67(3):287-93. PubMed ID: 15164984
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convection enhanced drug delivery of novel therapeutic agents to malignant brain tumors.
    Ferguson S; Lesniak MS
    Curr Drug Deliv; 2007 Apr; 4(2):169-80. PubMed ID: 17456036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crossing borders: surgically mediated drug delivery techniques.
    Asthagiri AR; Baggenstos M; Lonser RR
    Clin Neurosurg; 2008; 55():27-34. PubMed ID: 19248666
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
    Kunwar S; Chang S; Westphal M; Vogelbaum M; Sampson J; Barnett G; Shaffrey M; Ram Z; Piepmeier J; Prados M; Croteau D; Pedain C; Leland P; Husain SR; Joshi BH; Puri RK;
    Neuro Oncol; 2010 Aug; 12(8):871-81. PubMed ID: 20511192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of a patient-specific algorithm for simulating intracerebral drug infusions.
    Sampson JH; Raghavan R; Brady ML; Provenzale JM; Herndon JE; Croteau D; Friedman AH; Reardon DA; Coleman RE; Wong T; Bigner DD; Pastan I; Rodríguez-Ponce MI; Tanner P; Puri R; Pedain C
    Neuro Oncol; 2007 Jul; 9(3):343-53. PubMed ID: 17435179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved anti-tumor activity and safety of interleukin-13 receptor targeted cytotoxin by systemic continuous administration in head and neck cancer xenograft model.
    Kawakami K; Husain SR; Kawakami M; Puri RK
    Mol Med; 2002 Aug; 8(8):487-94. PubMed ID: 12435859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracerebral infusate distribution by convection-enhanced delivery in humans with malignant gliomas: descriptive effects of target anatomy and catheter positioning.
    Sampson JH; Brady ML; Petry NA; Croteau D; Friedman AH; Friedman HS; Wong T; Bigner DD; Pastan I; Puri RK; Pedain C
    Neurosurgery; 2007 Feb; 60(2 Suppl 1):ONS89-98; discussion ONS98-9. PubMed ID: 17297371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-13 fusion cytotoxin as a potent targeted agent for AIDS-Kaposi's sarcoma xenograft.
    Husain SR; Puri RK
    Blood; 2000 Jun; 95(11):3506-13. PubMed ID: 10828036
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.